NoopurSureshRajeMD

PubMed

• Correction to: Histone deacetylase (HDAC) inhibitor ACY241 enhances anti-tumor activities of antigen-specific central memory cytotoxic T lymphocytes against multiple m...
  Jooeun Bae, Teru Hideshima, Yu-Tzu Tai, Yan Song, Nikhil C Munshi, Paul Richardson, Noopur Raje, Kenneth C Anderson> ;Leukemia. 2024 Apr 15
• Practical Aspects of Immunotherapy: A Report from the 20th International Myeloma Society (IMS) Annual Meeting.
  Niels W C J van de Donk, Jesus San-Miguel, Noopur S Raje, Adam D Cohen, Krina K Patel, Joshua Richter> ;Clinical Lymphoma, Myeloma & Leukemia. 2024 Mar 22
• Design and Rationale of Prolonged Nightly Fasting for Multiple Myeloma Prevention (PROFAST): Protocol for a Randomized Controlled Pilot Trial.
  David J Lee, Elizabeth K O'Donnell, Noopur Raje, Cristina Panaroni, Robert Redd, Jennifer Ligibel, Dorothy D Sears, Omar Nadeem, Irene M Ghobrial, Catherine R Marinac> ;JMIR Research Protocols. 2024 Mar 11
• Cellular Mass Response to Therapy Correlates With Clinical Response for a Range of Malignancies.
  Stevens, M., Kimmerling, R., Olcum, S., Vacha, M., LaBella, R., Minnah, A., Katsis, K., Fujii, J., Shaheen, Z., Sundaresan, S., Criscitiello, J., Niesvizky, R., Raje, ...> ;JCO Precision Oncology. 2024 Jan 1
• 8 citations
  Elranatamab in relapsed or refractory multiple myeloma: the MagnetisMM-1 phase 1 trial.
  Nizar J Bahlis, Caitlin L Costello, Noopur S Raje, Moshe Y Levy, Bhagirathbhai Dholaria, Melhem Solh, Michael H Tomasson, Michael A Damore, Sibo Jiang, Cynthia Basu, A...> ;Nature Medicine. 2023 Oct 1
• 1 citations
  Radiation therapy as a bridging and salvage strategy in patients with relapsed or refractory multiple myeloma undergoing BCMA-targeted CAR T-cell therapy.
  Hazim S Ababneh, Andrew J Yee, Noopur S Raje, Sidney Martin, Matthew J Frigault, Andrea K Ng, Chirayu G Patel> ;Radiotherapy and Oncology. 2023 Dec 1
• Fracture rate after conventional external beam radiation therapy to the spine in multiple myeloma patients.
  Jens P Te Velde, Hester Zijlstra, Amanda Lans, Chirayu G Patel, Noopur Raje, Diyar Delawi, Diederik H R Kempen, Jorrit-Jan Verlaan, Barend J van Royen, Joseph H Schwab> ;The Spine Journal. 2024 Jan 1
• Clinical perspectives on the optimal use of lenalidomide plus bortezomib and dexamethasone for the treatment of newly diagnosed multiple myeloma.
  Paul G Richardson, Brian G Durie, Laura Rosiñol, Maria-Victoria Mateos, Angela Dispenzieri, Philippe Moreau, Shaji Kumar, Noopur Raje, Nikhil Munshi, Jacob P Laubach, ...> ;Haematologica. 2023 Nov 1
• 9 citations
  Idecabtagene vicleucel for relapsed and refractory multiple myeloma: post hoc 18-month follow-up of a phase 1 trial.
  Yi Lin, Noopur S Raje, Jesús G Berdeja, David S Siegel, Sundar Jagannath, Deepu Madduri, Michaela Liedtke, Jacalyn Rosenblatt, Marcela V Maus, Monica Massaro, Fabio Pe...> ;Nature Medicine. 2023 Sep 1
• 51 citations
  Elranatamab in relapsed or refractory multiple myeloma: phase 2 MagnetisMM-3 trial results.
  Alexander M Lesokhin, Michael H Tomasson, Bertrand Arnulf, Nizar J Bahlis, H Miles Prince, Ruben Niesvizky, Paula Rodrίguez-Otero, Joaquin Martinez-Lopez, Guenther Koe...> ;Nature Medicine. 2023 Sep 1
• 13 citations
  Monitoring, prophylaxis, and treatment of infections in patients with MM receiving bispecific antibody therapy: consensus recommendations from an expert panel.
  Noopur Raje, Kenneth Anderson, Hermann Einsele, Yvonne Efebera, Francesca Gay, Sarah P Hammond, Alexander M Lesokhin, Sagar Lonial, Heinz Ludwig, Philippe Moreau, Krin...> ;Blood Cancer Journal. 2023 Aug 1
• 2 citations
  It is worth the weight: obesity and the transition from monoclonal gammopathy of undetermined significance to multiple myeloma.
  Ruth Choa, Cristina Panaroni, Roma Bhatia, Noopur Raje> ;Blood Advances. 2023 Sep 26
• 1 citations
  Respiratory infections predominate after day 100 following B-cell maturation antigen-directed CAR T-cell therapy.
  Jessica S Little, Megha Tandon, Joseph Seungpyo Hong, Omar Nadeem, Adam S Sperling, Noopur Raje, Nikhil Munshi, Matthew Frigault, Sara Barmettler, Sarah P Hammond> ;Blood Advances. 2023 Sep 26
• 3 citations
  Time-Dependent Prognostic Value of Serological and Measurable Residual Disease Assessments after Idecabtagene Vicleucel.
  Bruno Paiva, Irene Manrique, Julie Rytlewski, Timothy Campbell, Christian C Kazanecki, Nathan Martin, Larry D Anderson Jr., Jesús G Berdeja, Sagar Lonial, Noopur S Raj...> ;Blood Cancer Discovery. 2023 Sep 1
• 6 citations
  Neurologic toxicities following adoptive immunotherapy with BCMA-directed CAR T cells.
  Philipp Karschnia, Kevin C Miller, Andrew J Yee, Kai Rejeski, P Connor Johnson, Noopur Raje, Matthew J Frigault, Jorg Dietrich> ;Blood. 2023 Oct 5
• Correction: Clinical evidence for immune-based strategies in early-line multiple myeloma: current challenges in decision-making for subsequent therapy.
  Noopur Raje, María-Victoria Mateos, Shinsuke Iida, Donna Reece> ;Blood Cancer Journal. 2023 Jul 6
• Plain language summary of the MAIA study of daratumumab plus lenalidomide and dexamethasone for the treatment of people with newly diagnosed multiple myeloma.
  Thierry Facon, Shaji K Kumar, Torben Plesner, Robert Z Orlowski, Philippe Moreau, Nizar Bahlis, Supratik Basu, Hareth Nahi, Cyrille Hulin, Hang Quach, Hartmut Goldschm...> ;Future Oncology. 2023 Apr 1
• 3 citations
  Immune Reconstitution and Vaccinations in Multiple Myeloma: A Report From the 19th International Myeloma Society Annual Workshop.
  Evangelos Terpos, Paola Neri, Niels W C J van de Donk, Mattia D'Agostino, Samir Parekh, Sundar Jagannath, Heinz Ludwig, David E Avigan, Noopur S Raje, Dhodapkar, M.> ;Clinical Lymphoma, Myeloma & Leukemia. 2023 Jun 1
• 4 citations
  Clinical evidence for immune-based strategies in early-line multiple myeloma: current challenges in decision-making for subsequent therapy.
  Noopur Raje, María-Victoria Mateos, Shinsuke Iida, Donna Reece> ;Blood Cancer Journal. 2023 Mar 22
• 19 citations
  Phase 1 study of CART-ddBCMA for the treatment of subjects with relapsed and refractory multiple myeloma.
  Matthew J Frigault, Michael R Bishop, Jacalyn Rosenblatt, Elizabeth K O'Donnell, Noopur Raje, Daniella Cook, Andrew J Yee, Emma Logan, David E Avigan, Andrzej Jakubowi...> ;Blood Advances. 2023 Mar 14
• 15 citations
  Ethical Challenges with Multiple Myeloma BCMA Chimeric Antigen Receptor T Cell Slot Allocation: A Multi-Institution Experience.
  Taxiarchis Kourelis, Radhika Bansal, Jesus Berdeja, David Siegel, Krina Patel, Sham Mailankody, Myo Htut, Nina Shah, Sandy W Wong, Surbhi Sidana, Andrew J Cowan, Melis...> ;Transplantation and Cellular Therapy. 2023 Apr 1
• 1 citations
  Carbon-11-Labeled Methionine PET/CT in Patients With FDG-Occult Multiple Myeloma: A Prospective Pilot Study.
  Yingbing Wang, Andrew Yee, Zachary Bernstein, Elizabeth O'Donnell, Noopur Raje, Umar Mahmood> ;AJR. American Journal of Roentgenology. 2023 Apr 1
• 18 citations
  Effect of granulocyte colony-stimulating factor on toxicities after CAR T cell therapy for lymphoma and myeloma.
  Kevin Charles Miller, Patrick Connor Johnson, Jeremy S Abramson, Jacob D Soumerai, Andrew J Yee, Andrew R Branagan, Elizabeth K O'Donnell, Anna Saucier, Caron A Jacobs...> ;Blood Cancer Journal. 2022 Nov 1
• 5 citations
  Quality of life, psychological distress, and prognostic perceptions in caregivers of patients with multiple myeloma.
  Elizabeth K O'Donnell, Yael N Shapiro, Andrew J Yee, Omar Nadeem, Jacob P Laubach, Andrew R Branagan, Kenneth C Anderson, Clifton C Mo, Nikhil C Munshi, Irene M Ghobri...> ;Blood Advances. 2022 Sep 13
• 1 citations
  Leaving Lytic Lesions-Is There New Role for Radiation in Multiple Myeloma in the CAR T Era?
  Hazim S Ababneh, Noopur S Raje, Andrew J Yee, Chirayu G Patel> ;Practical Radiation Oncology. 2022 Sep 4
• Join now to see all

Journal Articles

• Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma  
  Nikhil C Munshi, Larry D Anderson, Deepu Madduri, Sagar Lonial, Noopur Raje, Fabio Petrocca, Kristen Hege, The New England Journal of Medicine
• Twice‐Weekly Ixazomib in Combination with Lenalidomide‐Dexamethasone in Patients with Newly Diagnosed Multiple Myeloma  
  Myo Htut, Michaela Liedtke, Stephen D Smith, Craig C Hofmeister, Rachid Baz, Paul G Richardson, Cara A Rosenbaum, David H Vesole, Ajai Chari, Jesus G Berdeja, Noopur Raje, British Journal of Haematology
• Role of the RANK/RANKL Pathway in Multiple Myeloma  
  Noopur Raje, MD, Clinical Cancer Research
• A Phase 1/2 Study of Evofosfamide, A Hypoxia-Activated Prodrug with or Without Bortezomib in Subjects with Relapsed/Refractory Multiple Myeloma  
  Noopur S Raje, Ira Zackon, Clinical Cancer Research
• Join now to see all

Abstracts/Posters

• Progression-Free Survival Analysis of Denosumab Vs Zoledronic Acid in Intent to Transplant Multiple Myeloma Patients Based on Treatment Regimen and Baseline Characteri...
  Noopur S. Raje, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Outcomes of Patients with t(11;14) Multiple Myeloma: An International Myeloma Working Group Multicenter Study
  Noopur S. Raje, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Updated Results of a Phase 2 Study of Modified Lenalidomide, Bortezomib, and Dexamethasone (RVd-lite) in Transplant-Ineligible Multiple Myeloma
  Noopur S. Raje, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Determining Resistance Mechanisms in BRAF-mutated Multiple Myeloma
  Noopur S. Raje, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• A Phase II Study of Elotuzumab in Combination with Pomalidomide, Bortezomib, and Dexamethasone in Relapsed and Refractory Multiple Myeloma
  Noopur S. Raje, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Polyunsaturated Fatty Acid (PUFA) Signaling Induces Ferroptosis-Mediated Cell-Death in Multiple Myeloma
  Noopur S. Raje, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Updated Results from an Ongoing Phase 1 Clinical Study of bb21217 Anti-Bcma CAR T Cell Therapy
  Noopur S. Raje, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Mature Osteoblasts Promote Multiple Myeloma Survival through Cell-Cell Contact and Immune Modulation Mechanisms
  Noopur S. Raje, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Osteoclast-Induced Immunosuppression Occurs through Dysregulation of Immune Checkpoint Axes in Multiple Myeloma
  Noopur Raje, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Markers of Initial and Long-Term Responses to Idecabtagene Vicleucel (Ide-Cel; bb2121) in the CRB-401 Study in Relapsed/Refractory Multiple Myeloma
  Noopur S. Raje, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Circulating Tumor DNA in the Peripheral Blood As Early Predictor of Clinical Outcome in Relapsed/ Refractory Multiple Myeloma
  Noopur S. Raje, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Defining the Differentiation States of Multiple Myeloma at Single Cell Resolution Reveals Opportunities for Immunotherapy
  Noopur Raje, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Join now to see all

Lectures

• Hematologic Malignancies—Plasma Cell Dyscrasia 
  ASCO Annual Meeting 2019 - Chicago, IL - 6/3/2019
• Addressing Current Questions and Controversies in the Management of Multiple Myeloma, Amyloidosis and Waldenstr_m Macroglobulinemia (Part 2 of a 2-Part Series) 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
• Safety, Clinical Activity, Pharmacokinetics, and Pharmacodynamics from a Phase I Study of PF-06863135, a B-Cell Maturation Antigen (BCMA)_CD3 Bispecific Antibody, in P... 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
• Progression-Free Survival Subset Analysis - Denosumab Vs Zoledronic Acid in Bone Disease Treatment of Newly Diagnosed Multiple Myeloma: An International, Double-Blind,... 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Analysis of Hospitalization and Readmissions after CAR T Cell Therapy 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Addressing Current Questions and Controversies in the Management of Multiple Myeloma, Waldenstrom Macroglobulinemia, and Amyloidosis 
  60th American Society of Hematology Annual Meeting - 11/30/2018
• Managing Multiple Myeloma: What's Next? 
  60th American Society of Hematology Annual Meeting - 11/30/2018
• bb2121 anti-BCMA CAR T-cell therapy in patients with relapsed/refractory multiple myeloma: Updated results from a multicenter phase I study. 
  2018 ASCO Annual Meeting - Chicago, Illinois - 06/1/2018
• Join now to see all